Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

Warning: foreach() argument must be of type array|object, null given in /var/www/wordpress/wp-content/themes/awaken-child/single-newsletter.php on line 54

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Treatment
  4. /
  5. ciprofloxacin DPI

ciprofloxacin DPI

April 12, 2017
ciprofloxacin DPI
Trade Name Ciprofloxacin Pulmosphere(R)
Orphan Indication Cystic fibrosis
USA Market Approval USA
USA Designation Date 2010-02-02 00:00:00
Sponsor Bayer HealthCare Pharmaceuticals, Inc.;100 Bayer Blvd, P. O. Box 915;Whippany, New Jersey, 07981
Related Access Program
Vertex Pharmaceuticals Incorporated – Cystic Fibrosis

Related Treatment

  • Anti-sense oligonucleotide consisting of 2�0-Me RNA with a phosphoro
  • Tezacaftor and Ivacaftor combination therapy
  • Tobramycin for inhalation
  • Tiotropium bromide
  • S-nitrosoglutathione
More Treatment
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2023 CheckOrphan.
    Developed by: Gonza.io logo Developed by: WebOptimalSolutions Powered by: Cloudscale logo